Bill Wilson, MD: GIPs and GLP-1s Are Transforming Metabolic Health and CARB Syndrome Treatment
Dr. Bill Wilson explains how GLP-1 drugs and newer GIP/GLP-1 combinations are being used beyond diabetes and obesity to treat heart, kidney, liver, and neurological problems. He says GIPs appear to supercharge GLP-1s, though most uses outside diabetes remain off-label.
Questions this video answers
April 22, 2025.
1) Type 2 diabetes (number one); 2) Obesity (number two).
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet